Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-26-000144
Filing Date
2026-03-25
Accepted
2026-03-25 16:16:09
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS amrx015308-defa14a.htm DEFA14A 9204
2 GRAPHIC check.jpg GRAPHIC 1441
3 GRAPHIC uncheck.jpg GRAPHIC 1060
4 GRAPHIC logo.jpg GRAPHIC 18550
5 GRAPHIC notice1.jpg GRAPHIC 2369067
6 GRAPHIC notice2.jpg GRAPHIC 1760048
  Complete submission text file 0001308179-26-000144.txt   5725476
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38485 | Film No.: 26792644
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)